Joseph Adrian Tyndall's most recent trade in Axogen Inc. was a trade of 14,150 Restricted Stock Units done . Disclosure was reported to the exchange on June 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Axogen Inc. | Joseph Adrian Tyndall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2025 | 14,150 | 14,150 | - | - | Restricted Stock Units | |
| Axogen Inc. | Joseph Adrian Tyndall | Director | Sale of securities on an exchange or to another person at price $ 10.72 per share. | 10 Jun 2025 | 26,931 | 0 (0%) | 0% | 10.7 | 288,700 | Common Stock |
| Axogen Inc. | Joseph Adrian Tyndall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.30 per share. | 10 Jun 2025 | 7,586 | 22,931 (0%) | 0% | 6.3 | 47,792 | Common Stock |
| Axogen Inc. | Joseph Adrian Tyndall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2025 | 7,586 | 0 | - | - | Stock Option (right to purchase) | |
| Axogen Inc. | Joseph Adrian Tyndall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.04 per share. | 10 Jun 2025 | 4,000 | 26,931 (0%) | 0% | 7.0 | 28,160 | Common Stock |
| Axogen Inc. | Joseph Adrian Tyndall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2025 | 4,000 | 14,248 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Joseph Adrian Tyndall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 12,850 | 7,586 | - | - | Stock Option (right to purchase) | |
| Axogen Inc. | Joseph Adrian Tyndall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.30 per share. | 22 May 2025 | 12,850 | 35,407 (0%) | 0% | 6.3 | 80,955 | Common Stock |
| Axogen Inc. | Joseph Adrian Tyndall | Director | Sale of securities on an exchange or to another person at price $ 11.20 per share. | 22 May 2025 | 12,850 | 22,557 (0%) | 0% | 11.2 | 143,920 | Common Stock |
| Axogen Inc. | Joseph Adrian Tyndall | Director | Sale of securities on an exchange or to another person at price $ 11.20 per share. | 22 May 2025 | 7,212 | 15,345 (0%) | 0% | 11.2 | 80,774 | Common Stock |
| Axogen Inc. | Joseph Adrian Tyndall | Director | Sale of securities on an exchange or to another person at price $ 11.63 per share. | 19 May 2025 | 2,525 | 22,557 (0%) | 0% | 11.6 | 29,366 | Common Stock |
| Axogen Inc. | Joseph Adrian Tyndall | Director | Purchase of securities on an exchange or from another person at price $ 10.50 per share. | 31 Dec 2024 | 2,525 | 25,082 (0%) | 0% | 10.5 | 26,513 | Common Stock |
| Axogen Inc. | Joseph Adrian Tyndall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 11,904 | 0 | - | - | Restricted Stock Units | |
| Axogen Inc. | Joseph Adrian Tyndall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 11,904 | 22,557 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Joseph Adrian Tyndall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 18,248 | 18,248 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Joseph Adrian Tyndall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 10,653 | 10,653 (0%) | 0% | - | Common Stock | |
| Axogen Inc. | Joseph Adrian Tyndall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 43,171 | 43,171 | - | - | Stock Option (right to purchase) |